Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
Author:
Funder
University of Maryland School of Medicine and Comprehensive Cancer Center Start-Up Fund
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference41 articles.
1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2018
2. Treating breast cancer in the 21st century: emerging biological therapies;Tinoco;J. Canc.,2013
3. Treatment for the endocrine resistant breast cancer: current options and future perspectives;Liu;J. Steroid Biochem. Mol. Biol.,2017
4. The fate of chemoresistance in triple negative breast cancer (TNBC);O'Reilly;BBA Clin.,2015
5. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice;Maximov;Curr. Clin. Pharmacol.,2013
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pyrimidine–triazole‐tethered tert‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation;IUBMB Life;2024-09-14
2. Bazedoxifene Inhibits Cell Viability, Colony‐Forming Activity, and Cell Migration in Human Non–Small Cell Lung Cancer Cells and Improves the Treatment Efficacy of Paclitaxel and Gemcitabine;The Clinical Respiratory Journal;2024-08
3. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha;Bioorganic Chemistry;2024-06
4. Strong Protection by Bazedoxifene Against Chemically-Induced Ferroptotic Neuronal DeathIn VitroandIn Vivo;2024-05-31
5. Water extract of sporoderm-broken spores of Ganoderma lucidum elicits dual antitumor effects by inhibiting p-STAT3/PD-L1 and promoting ferroptosis in castration-resistant prostate cancer;Journal of Functional Foods;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3